Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 75

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 75
---
1,239,646 | ) |
| Portion of Enterprise Value  
 Attributable to Shareholders |     | $ |    708,916 |   |
| Fair Value per Shares        |     | $ |     0.0155 |   |

The abovementioned constitutes the Company’s sole related party investment securities as of June 30, 2025.

<div align='center'>57</div>

6. ACCRUED EXPENSES

Accrued Expenses were comprised of the following:

|                        |     |   | June 30, 2025 |     |   | September 30, 2024 |
|:-----------------------|:----|:--|--------------:|:----|:--|-------------------:|
| Accrued payroll taxes  |     | $ |        28,753 |     | $ |              4,241 |
| Accrued Interest       |     |   |       434,852 |     |   |            362,533 |
| Accrued Payroll        |     |   |     1,206,630 |     |   |          1,256,630 |
| Accrued Rent           |     |   |        62,500 |     |   |                  - |
| Other Accrued Expenses |     |   |        41,423 |     |   |             41,423 |
| Toal notes payable     |     | $ |     1,774,158 |     | $ |          1,664,827 |

7. UNEARNED INCOME

Unearned income is attributable to payments made to the Company and its wholly owned subsidiary pursuant to two license agreements for which income is recognized over the terms of the agreement.

8. NOTES PAYABLE

Notes payable consisted of the following:

|                                 |     | June 30, 2025 |   |     | September 30, 2024 |         |   |
|:--------------------------------|:----|:--------------|:--|:----|:-------------------|--------:|:--|
| Bostonia Partners, Inc.         |     | $             | - |     | $                  |  48,500 |   |
| Conventry Enterprises LLC       |     |               | - |     |                    | 250,000 |   |
| Total notes payable             |     |               | - |     |                    | 248,500 |   |